Standard
Breakthrough Study Identifies Potential Therapeutic Target to Curb Harmful Brain Inflammation
In a development that could reshape the treatment landscape for a host of debilitating neurological and psychiatric conditions, scientists at the University of Birmingham have unveiled a promising new strategy to mitigate harmful brain inflammation. Led by Professor Nicholas Barnes, the research team has successfully identified the P2X7 receptor as a pivotal driver of neuroinflammation,…
